Board of directors (9)
Directors with a Section 16 filing in the last 13 months. “Since” is the first filing as a director; SEC data sets start in 2016.
Executive officers (10)
Company facts
- Chair
- —
- In S&P 500 since
- Jan 2016
- Incorporated in
- L2
- Fiscal year ends
- December
- SEC industry
- Insurance Agents, Brokers & Service
- SEC filings
- EDGAR
Connections to other S&P 500 companies
Current directors and officers who also hold a role at another S&P 500 company.
Major holders (5% or more)
Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.
No 5% holder filings parsed yet for this company.
Insider trades
Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | Alexis Faber Chief Operating Officer | Sale | 730 | $342.70 | $250K |
| May 6, 2026 | Lucy Clarke President of Risk & Broking | Buy | 1,896 | $263.37 | $499K |
| May 4, 2026 | Carl Aaron Hess Chief Executive Officer | Buy | 2,000 | $255.08 | $510K |
| Mar 3, 2026 | Matthew Furman General Counsel | Sale | 3,000 | $304.00 | $912K |
| Feb 13, 2026 | Lucy Clarke President of Risk & Broking | Buy | 3,500 | $284.84 | $997K |
| Feb 12, 2026 | Michael P. Hammond Director | Buy | 241 | $278.86 | $67K |
| Jun 3, 2025 | Andrew Jay Krasner Chief Financial Officer | Sale | 1,600 | $315.75 | $505K |
| May 8, 2025 | Carl Aaron Hess Chief Executive Officer | Sale | 192 | $307.91 | $59K |
| May 8, 2025 | Carl Aaron Hess Chief Executive Officer | Sale | 2,891 | $309.67 | $895K |
| May 8, 2025 | Carl Aaron Hess Chief Executive Officer | Sale | 709 | $310.74 | $220K |
| May 8, 2025 | Carl Aaron Hess Chief Executive Officer | Sale | 146 | $306.85 | $45K |
| May 8, 2025 | Carl Aaron Hess Chief Executive Officer | Sale | 6,062 | $308.78 | $1.9M |
| May 8, 2025 | Alexis Faber Chief Operating Officer | Sale | 265 | $306.92 | $81K |
| Mar 3, 2025 | Julie Jarecke Gebauer Pres.-Health, Wealth & Career | Sale | 1,616 | $338.74 | $547K |
| Feb 28, 2025 | Julie Jarecke Gebauer Pres.-Health, Wealth & Career | Sale | 3,384 | $335.77 | $1.1M |
| Mar 1, 2024 | Andrew Jay Krasner Chief Financial Officer | Sale | 1,100 | $272.13 | $299K |
| Feb 20, 2024 | Julie Jarecke Gebauer Pres.-Health, Wealth & Career | Sale | 5,000 | $276.03 | $1.4M |
| Feb 8, 2024 | Adam Garrard Head of Risk & Broking | Sale | 5,400 | $270.41 | $1.5M |
| Nov 9, 2023 | Pamela Thomson-Hall Head of International | Sale | 330 | $238.87 | $79K |
| Jul 3, 2023 | Julie Jarecke Gebauer Pres.-Health, Wealth & Career | Sale | 600 | $231.41 | $139K |
| Jul 3, 2023 | Julie Jarecke Gebauer Pres.-Health, Wealth & Career | Sale | 500 | $234.82 | $117K |
| Jul 3, 2023 | Julie Jarecke Gebauer Pres.-Health, Wealth & Career | Sale | 900 | $230.14 | $207K |
| Jun 7, 2023 | Anne Pullum Co-Head of Corporate Dev. | Sale | 5,000 | $224.45 | $1.1M |
| Jun 1, 2023 | Julie Jarecke Gebauer Pres.-Health, Wealth & Career | Sale | 2,500 | $218.35 | $546K |
| May 1, 2023 | Julie Jarecke Gebauer Pres.-Health, Wealth & Career | Sale | 2,500 | $231.44 | $579K |
Board and executive changes
Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.
- Nov 3, 2026
As previously disclosed by Willis Towers Watson Public Limited Company (the “Company”), Joseph Kurpis notified the Company of his intent to retire from his role as the Company’s Principal Accounting Officer and Controller. On November 3, 2026, the Company announced that Steven Alcock, 47, was appointed to succeed Mr. Kurpis as the Principal Accounting Officer and Controller of the Company, effective as of April 1, 2027. Mr. Alcock has served as Head of Finance, International of the Company since January 2022. Since December 2025, Mr. Alcock has also served as Chief Financial Officer of Willis Limited, a regulated U.K. subsidiary of the Company. Prior to holding such roles, Mr. Alcock held several senior accounting and finance leadership roles since he joined the Company in 1997. There are no arrangements or understandings between Mr.
Read the 8-K filing - Mar 3, 2025
On February 25, 2025, Paul Thomas, the current Non-Executive Chair of the Board of Directors (the “Board”) of Willis Towers Watson Public Limited Company (the “Company”), informed the Board that he intends to retire at the end of his current term and will not stand for reelection at the Company’s 2025 Annual Meeting of Stockholders (“AGM”). Mr. Thomas’s retirement is not a result of any disagreement with the Company. The Board has selected Paul Reilly, an independent director of the Board, to become the Non-Executive Chair of the Board effective as of the conclusion of the 2025 AGM, subject to his re-election. Mr. Reilly has been an independent director of the Board since October 2022. On March 3, 2025, the Company announced the retirement of Mr. Thomas and the selection of Mr. Reilly as the next Non-Executive Chair of the Board.
Read the 8-K filing - Jul 24, 2023
On July 24, 2023, Willis Towers Watson Public Limited Company announced that, in the third quarter of 2024, Adam Garrard will assume the role of chairman, Risk and Broking, upon the arrival of Lucy Clarke as president, Risk & Broking.
Read the 8-K filing - Dec 9, 2022
On December 7, 2022, the Board of Directors (the “Board”) of Willis Towers Watson (the “Company”) appointed Mr. Stephen Chipman, Ms. Jackie Hunt, and Mr. Fredric Tomczyk to the Board, each with a start date effective April 1, 2023. In addition, two current directors, Mr. Brendan O’Neill and Ms. Linda Rabbitt, gave notice to the Company that they will not be standing for re-election at the Company’s next Annual General Meeting, to be held in the second quarter of 2023. Each has decided not to stand for re-election in light of other commitments and in furtherance of the Board succession plan. There is no disagreement between the Company and either Mr. O’Neill or Ms. Rabbitt on any matter relating to the Company’s operations, policies or practices.
Read the 8-K filing - Feb 28, 2022
On February 22, 2022, the Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of Willis Towers Watson Public Limited Company, a corporation organized under the laws of Ireland (the “Company”), approved, and the Board ratified, changes to the short-term incentive compensation program (“STI Program”) and the long-term incentive compensation program (the “LTI Program” and together with the STI Program, the “Incentive Programs”) for the Company’s executive officers for 2022. These changes are intended to support a unified, team mindset as the Company aims to advance its new business strategy. On February 22, 2022, the Compensation Committee also approved, and the Board ratified, certain amendments to the Willis Towers Watson Public Limited Company Severance and Change in Control Pay Plan for U.S. Executives (as amended, the “U.S.
Read the 8-K filing - Dec 30, 2021
On December 28, 2021, each of Anna Catalano, Wendy Lane and Wilhelm Zeller provided notice to Willis Towers Watson Public Limited Company (the “Company”) that they had definitively concluded that they will not be standing for re-election to the Board of Directors (the “Board”) at the 2022 Annual General Meeting of Shareholders (“AGM”). As previously announced in November, Victor Ganzi had given notice that he will not be standing for re-election to the Board at the 2022 AGM. There is no disagreement between the Company and any of these directors on any matter relating to the Company’s operations, policies or practices.
Read the 8-K filing - Dec 10, 2021
(e) Compensatory arrangements of certain officers. On December 6, 2021, the Compensation Committee (the “Committee”) of Willis Towers Watson Public Limited Company (the “Company”) approved, with the full Board of Directors ratifying, a 2022 Long-Term Incentive (“LTI”) Compensation award target for Mr. Carl Hess of $7.25 million in connection with his appointment to Chief Executive Officer of the Company, effective January 1, 2022. As CEO, Mr. Hess will receive a 2022 base salary of $1 million and a target Short-Term Incentive (“STI”) award of 175% of that base salary. His base salary and STI target were approved in connection with his promotion to President of the Company earlier this year and will be used to establish his STI for 2021. He did not receive an increase in his 2021 LTI award in connection with his promotion to President.
Read the 8-K filing - Nov 19, 2021
On November 18, 2021, the Board of Directors (the “Board”) of Willis Towers Watson (the “Company”) announced its appointments of Ms. Inga Beale, Ms. Fumbi Chima, Mr. Michael Hammond, and Ms. Michelle (Shelly) Swanback to the Board, with such appointments effective January 1, 2022 in the case of Ms. Beale, Mr. Hammond and Ms. Swanback, and April 1, 2022, in the case of Ms. Chima. In order to facilitate the director transition process, Mr. Jaymin Patel has decided to step down from the Board on January 1,2022, at the time three of the new directors join the Board. Mr. Patel had previously been considering transitioning off the Board at the end of his term to spend more time on other commitments and agreed to accelerate his departure to coincide with new directors’ joining the Board. In addition, Mr.
Read the 8-K filing - Sep 24, 2021
On September 20, 2021, the Compensation Committee of the Board of Directors (the “Board”) of Willis Towers Watson Public Limited Company (the “Company”) approved changes in compensation for Carl Hess in connection with his appointment as the Company’s President as of August 16, 2021, including (i) an annual base salary of $1,000,000 and (ii) a target short-term incentive bonus of 175% of his base salary, in each case, effective as of September 1, 2021.
Read the 8-K filing - Sep 3, 2021
On August 30, 2021, Willis Towers Watson Public Limited Company (the “Company”) announced a number of management changes, including the appointment of a new chief operating officer, one of the roles specifically covered by the disclosure requirements of
Read the 8-K filing - Aug 30, 2021
On August 30, 2021, Willis Towers Watson plc (the “Company”) announced that Andrew Krasner, 45, will succeed Michael J. Burwell as Chief Financial Officer, effective as of September 7, 2021. Mr. Burwell resigned from the Company on August 26, 2021, effective as of September 30, 2021, although he will step down as Chief Financial Officer upon Mr. Krasner’s commencement of employment. In connection with his resignation, Mr. Burwell (i) will receive a completion bonus of $1 million as he transitions his position and to reflect his achievements during a challenging year, and 3 months of COBRA coverage and (ii) the unvested portion of his Non-Qualified Deferred Savings Plan and Non-qualified Stable Value Excess Plan totaling 2,443 shares will vest. He will forfeit his outstanding 2019, 2020, and 2021 Operating Committee Long-Term Incentive Plan awards. Following his resignation, Mr.
Read the 8-K filing - Aug 16, 2021
On August 16, 2021, Willis Towers Watson Public Limited Company (“Willis Towers Watson”) announced that its Board of Directors has appointed Carl Hess as President of Willis Towers Watson, effective immediately, and to succeed John Haley as Chief Executive Officer of Willis Towers Watson, effective January 1, 2022. The Company’s Board of Directors has not yet determined Mr Hess’s compensation as Chief Executive Officer. Mr. Hess has previously served as head of Willis Towers Watson’s Investment, Risk and Reinsurance segment since January 2016.
Read the 8-K filing - May 20, 2021
On May 17, 2021, Mr. Joseph Kurpis, 61, was appointed as the Controller & Principal Accounting Officer of Willis Towers Watson Public Limited Company. Mr. Kurpis previously served as the Global Assistant Controller since April 2016.
Read the 8-K filing - May 6, 2021
On April 30, 2021, Susan D. Davies, the current Controller & Principal Accounting Officer, informed Willis Towers Watson plc (the “Company”) that she will be resigning from the Company as of May 18, 2021. It is expected that on May 17, 2021, Mr. Joseph Kurpis will be appointed as her successor. In connection with Ms. Davies’ resignation, there were no disagreements with the Company relating to the Company’s operations, financials, policies or practices.
Read the 8-K filing - Feb 5, 2021
(e) Compensatory arrangements of certain officers. On February 2, 2021, the Compensation Committee of the Board of Directors of Willis Towers Watson Public Limited Company, a corporation organized under the laws of Ireland (the “ Company ”), approved retention agreements (the “ Retention Agreements ”) to be entered into with certain executives, including Michael Burwell, Gene Wickes, Carl Hess, and Joseph Gunn (the “ Executives ”), in order to further incentivize their continued employment to assist with the Company’s continuing business through the anticipated closing of the combination of the Company and Aon plc, a company incorporated under the laws of England and Wales (“ Aon ”), pursuant to the Business Combination Agreement dated as of March 9, 2020 (the “ Business Combination ”).
Read the 8-K filing
Show 18 older changes
- Jun 15, 2020
On June 12, 2020, Willis Towers Watson Public Limited Company (the “Company”) entered into an amendment with John Haley (the “Amendment”) to amend his employment agreement with the Company, dated as of March 1, 2016, as amended on July 18, 2018 and May 20, 2019 (the “Employment Agreement”). Pursuant to the Amendment, the Employment Agreement will remain in full force and effect, and is modified as described below. The term of the Employment Agreement is extended until the later of (i) December 31, 2020 and (ii) the “effective date” as defined under the Business Combination Agreement with Aon plc (the “BCA Effective Date”). However, if the BCA Effective Date does not occur prior to December 31, 2021, the term will expire on such date. As a result of the Amendment, the non-competition, non-solicitation, and other restrictive covenants to which Mr.
Read the 8-K filing - Jun 5, 2020
(e) On June 5, 2020, Willis Towers Watson Public Limited Company, a corporation organized under the laws of Ireland (the “ Company ”), adopted changes to the short-term incentive compensation program (the “ STI Program ”) for the Company’s executive officers for 2020. The general principles applicable to the STI Program for the Company’s broader base of employees have not been changed.
Read the 8-K filing - Mar 11, 2020
On March 8, 2020, our board of directors approved the Willis Towers Watson Public Limited Company Severance and Change in Control Pay Plan for U.S. Executives (the “ U.S. Severance Plan ”) and the Willis Towers Watson Severance and Change in Control Pay Plan for Non-U.S. Executives (the “ Non-U.S. Severance Plan ,” and together, the “ Severance Plans ”). The U.S. Severance Plan is intended to be a severance pay plan governed by Title I of ERISA primarily for the purpose of providing benefits for a select group of management or highly compensated employees based in the U.S. and the Non-U.S. Severance Plan is intended to accommodate the requirements of local non-U.S. laws. Of our named executive officers, Michael Burwell and Gene Wickes have been selected to participate in the Severance Plans. John Haley will not be participating in the U.S.
Read the 8-K filing - Aug 15, 2019
On August 14, 2019, Willis Towers Watson Public Limited Company (the “Company”) announced that Adam Garrard, the current head of International, will become the head of the Corporate Risk and Broking segment, effective immediately. Todd Jones, the current head of the Corporate Risk and Broking segment and a “named executive officer” in the latest proxy statement, will be leaving the Company for a role at another company.
Read the 8-K filing - May 8, 2019
On May 8, 2019, Willis Towers Watson Public Limited Company (the “Company”) announced several changes, effective immediately, to the structure of the Operations and Technology functions that report to Michael Burwell, the Chief Financial Officer. As part of these changes, the position of Head of Operations and Technology will be eliminated; the functions currently associated with that position will either report directly to Mr. Burwell or to his direct reports; and David Shalders, the current Head of Operations and Technology and a “named executive officer” in the latest proxy statement, will cease to have that title and will be leaving the Company.
Read the 8-K filing - Mar 1, 2019
(b) Retirement of Directors On February 26, 2019, James McCann announced his intention to retire from the Board of Directors of Willis Towers Watson Public Limited Company (the “Company”). He will serve the remainder of his term and will not seek re-election at the 2019 Annual General Meeting of Shareholders (the “2019 AGM”). Accordingly, at the 2019 AGM (currently anticipated to be on May 20, 2019), he will retire from the Board and all Board Committees. Mr. McCann’s retirement follows almost 15 years of service on the Board and various Board Committees, with almost seven years of service as Non-Executive Chairman or Lead Independent Director of the Company and its Willis predecessor. This includes serving as Non-Executive Chairman during the three-year period following the merger of Willis and Towers Watson.
Read the 8-K filing - Jul 18, 2018
On July 18, 2018, Willis Towers Watson Public Limited Company (the “ Company ”) announced that it has extended its contract with John J. Haley, Chief Executive Officer, through January 1, 2021, on which date Mr. Haley plans to retire. In light of Mr. Haley’s continued leadership of the Company, and in order to facilitate an orderly succession of the Chief Executive Officer position, the Company and Mr. Haley entered into an amendment (the “ Amendment Agreement ”) to that certain employment agreement, dated as of March 1, 2016, by and between the Company and Mr. Haley (the “ Employment Agreement ”). The Amendment Agreement is attached as Exhibit 99.2 and incorporated herein by reference.
Read the 8-K filing - Nov 17, 2017
On November 14, 2017, Jeffrey W. Ubben, a director of Willis Towers Watson Public Limited Company (the “Company”), notified the Company’s Board of Directors of his resignation as a director. His resignation was effective as of November 15, 2017. Mr. Ubben is not resigning due to any disagreement with the Company on any matter relating to its operations, policies or practices.
Read the 8-K filing - Aug 21, 2017
On August 21, 2017, Willis Towers Watson Public Limited Company (the “ Company ”) announced that Mr. Michael J. Burwell will become the Company’s new Chief Financial Officer, effective October 2, 2017. Mr. Burwell, 53, will join the Company with over 30 years of finance experience from his tenure at PricewaterhouseCoopers LLP, where he has served as a Senior Partner driving Transformation activities with various clients across industries since 2016. Mr. Burwell has served in various senior leadership roles at PricewaterhouseCoopers, including, most recently, Vice Chairman, Global and US Transformation Leader from 2012 to 2016, Vice Chairman, US Operations Leader (COO) and Chief Financial Officer from 2007 to 2012, and Leader of the Transaction Services practice from 2005 to 2007. An offer letter, dated August 17, 2017, (the “Agreement”), sets forth the terms of Mr.
Read the 8-K filing - Apr 6, 2017
(b) On April 6, 2017, Roger Millay, the Chief Financial Officer of Willis Towers Watson Public Limited Company (the “Company”), provided notice to the Company that he will voluntarily retire effective October 2, 2017. The Company’s related press release is attached as Exhibit 99.1 and is incorporated by reference herein.
Read the 8-K filing - Feb 13, 2017
(e) On February 7, 2017, the Compensation Committee (the “ Committee ”) of the Board of Directors of Willis Towers Watson Public Limited Company, a company organized under the laws of Ireland (the “ Company ”), approved a change to the financial metrics used for the performance goals that apply to annual awards granted under the Company’s Annual Incentive Plan (“ AIP ”) to each of the executive officers of the Company, including the Company’s named executive officers. Under the existing AIP structure, each officer is eligible to receive an annual award expressed as a percentage of the officer’s base salary.
Read the 8-K filing - Oct 27, 2016
On October 27, 2016, Willis Towers Watson Public Limited Company (the “Company”) announced several leadership changes, effective immediately, including a change impacting Tim Wright, who was a “named executive officer” in the Company’s most recent Proxy Statement. These changes include the following: • Todd Jones, Co-head of North America, will be changing roles to become the Head of Corporate Risk and Broking. • Carl Hess, Co-head of North America, will be changing roles to become the Head of Investment, Risk and Reinsurance. • Joe Gunn, Northeast Region Lead of North America, will be changing roles to become the Head of North America. • Anne Pullum, Head of Strategy, will be taking on additional responsibilities as the Chief Administrative Officer for Willis Towers Watson.
Read the 8-K filing - Oct 26, 2016
On October 25, 2016, Willis Towers Watson Public Limited Company (“Willis Towers Watson”) and Mr. Dominic Casserley confirmed that Mr. Casserley will be leaving the company following the expiration of his employment agreement on December 31, 2016. Therefore, Mr. Casserley will resign as President and Deputy Chief Executive Officer and as a member of our board of directors, effective December 31, 2016, at the conclusion of his employment term.
Read the 8-K filing - Jul 26, 2016
(e) On July 20, 2016, the Compensation Committee (the “Committee”) of the Board of Directors of Willis Towers Watson Public Limited Company, a company organized under the laws of Ireland (the “Company”), approved a change to the financial metrics used for the performance goals that apply to annual awards granted under the Company’s Annual Incentive Plan (“AIP”) to each of the executive officers of the Company, including the Company’s named executive officers. Under the existing AIP structure, each officer is eligible to receive an annual award expressed as a percentage of the officer’s base salary.
Read the 8-K filing - Jun 16, 2016
(e) As previously disclosed by Willis Towers Watson Public Limited Company (the “ Company ”) in Current Report on Form 8-K, filed on March 1, 2016, the Company entered into an employment agreement with Mr. Haley upon his appointment as the Company’s Chief Executive Officer and, in connection with such employment agreement, announced its intention to grant a supplemental restricted share unit award upon shareholder approval of amendments to the Company’s 2012 Equity Incentive Plan, including an increase in the number of shares authorized for issuance under the Plan. As discussed in
Read the 8-K filing - Mar 1, 2016
(e) Employment Agreement Willis Towers Watson Public Limited Company, an Irish public limited company (the “ Company ”) has entered into an Employment Agreement with its Chief Executive Officer, John J. Haley (the “ Employment Agreement ”), effective March 1, 2016, memorializing the terms of his employment as summarized below. Term. The term of the Employment Agreement is from March 1, 2016 through December 31, 2018, unless otherwise extended by mutual agreement of the parties. Base Salary. Under the Employment Agreement, Mr. Haley’s annual base salary will increase from $1.04 million to $1.2 million. A portion of his salary in excess of $1 million may be deferred until his retirement under a compensation deferral plan in order to maximize the tax deductibility of Mr. Haley’s compensation under Section 162(m) of the Internal Revenue Code. Benefits. Mr.
Read the 8-K filing - Feb 8, 2016
(c) On February 4, 2016, the Board of Directors of Willis Towers Watson appointed Susan D. Davies to the roles of the company’s controller and principal accounting officer for the company, effective February 4, 2016. Ms. Davies (age 47) previously served as the controller and principal accounting officer for Towers Watson & Co. from November 13, 2015 to January 4, 2016, and before that she was Global Director of Internal Audit for Towers Watson since March 2010. Ms. Davies previously held the same position in an interim capacity for Watson Wyatt and Towers Watson from October 2009 through March 2010. Prior to that, Ms. Davies served as the Director of Internal Audit for the Americas for Watson Wyatt from November 2007 to October 2009. Prior to joining Watson Wyatt, Ms. Davies served in various roles with PricewaterhouseCoopers from 1997 to 2007. 2
Read the 8-K filing - Jan 5, 2016
As previously disclosed in Willis’ Current Report on Form 8-K filed with the SEC on December 22, 2015, in anticipation of the combination of Willis and Towers Watson & Co., the board of directors of Willis approved, effective as of the Effective Time, the resignation of certain directors of Willis and the appointment of the director designees of Towers Watson. The board of directors of Willis also appointed James McCann as Chairman of the Board of Willis Towers Watson and determined that all members of the board of directors of Willis Towers Watson (other than Messrs. John J. Haley and Dominic Casserley) were independent within the meaning of the independent director standards of the SEC and under the NASDAQ qualification standards.
Read the 8-K filing
Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021
Share price
Annual financials
From the company's 10-K XBRL data (SEC companyfacts).
| Fiscal year | Revenue | Net income | Margin | Diluted EPS | Total assets |
|---|---|---|---|---|---|
| FY2025 | $9.7B | $1.6B | 16.5% | $16.26 | $29.5B |
| FY2024 | $9.9B | -$98.0M | -1.0% | $-0.96 | $27.7B |
| FY2023 | $9.5B | $1.1B | 11.1% | $9.95 | $29.1B |
| FY2022 | $8.9B | $1.0B | 11.4% | $8.98 | $31.8B |
| FY2021 | $9.0B | $4.2B | 46.9% | $32.78 | $35.0B |
| FY2020 | $8.6B | $996.0M | 11.6% | $7.65 | $38.5B |
| FY2019 | $8.4B | $1.0B | 12.5% | $8.02 | $35.4B |
| FY2018 | $8.5B | $695.0M | 8.2% | $5.27 | $32.4B |
Former directors and officers (33)
People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.